China Drug Approvals | 2024 | iPharmaCenterJanuary 02, 2023 Beyfortus was approved in China for Preventing RSV Disease in Infants AstraZeneca and Sanofi's Beyfortus (nirsevimab), a...
China Drug Approvals | 2023 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenterDecember 21, 2023 Takeda's Livtencity was approved in China for CMV infections Takeda declares the approval from China NMPA for...
China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenterTakeda announced that the National Medical Products Administration (NMPA) of China approved Exkivity (mobocertinib) for treating adults...
China Healthcare News | Drug News | iPharmaCenterDecember 23, 2022 Eisai initiated data submission for BLA of lecanemab in China for Alzheimer's Eisai and Biogen announced that they have...